Ra. Houghtling et al., CHARACTERIZATION OF (+ -)-[H-3]EPIBATIDINE BINDING TO NICOTINIC CHOLINERGIC RECEPTORS IN RAT AND HUMAN BRAIN/, Molecular pharmacology, 48(2), 1995, pp. 280-287
Epibatidine is an alkaloid that was first isolated from the skin of th
e Ecuadoran frog Epipedobates tricolor by Daly el al. [J. Am. Chem. Se
c. 102:803-836 (1980)] and was found to have very high affinity for ne
uronal nicotinic receptors, where it acts as a potent agonist. Here we
have measured and characterized the binding of (+/-)-[H-3]epibatidine
to nicotinic receptors in rat brain. In rat forebrain homogenates, (/-)-[H-3]epibatidine binds to two sites, with apparent affinities of 1
5 pM and 360 pM. Both of these binding sites have pharmacological prof
iles consistent with neuronal nicotinic receptors and a similar brain
regional distribution. (+/-)-[H-3]Epibatidine also binds to sites in r
at adrenal gland, suggesting that it can label a subtype of nicotinic
receptor found in peripheral ganglia as well as the subtype that predo
minates in brain. In human cerebral cortex as well, (+/-)-[H-3]epibati
dine binds two sites, one of which appears to have an affinity of < 1
pM. We conclude that (+/-)-[H-3]epibatidine should be a very useful ne
w tool for characterizing the properties and regulation of neuronal ni
cotinic receptors, including those not easily measurable with other ra
dioligands.